1. Home
  2. DNOW vs BCRX Comparison

DNOW vs BCRX Comparison

Compare DNOW & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

HOLD

Current Price

$12.89

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.88

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNOW
BCRX
Founded
1862
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
DNOW
BCRX
Price
$12.89
$8.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$16.67
$20.82
AVG Volume (30 Days)
2.4M
3.9M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
381.40
EPS
N/A
1.21
Revenue
$2,648,000,000.00
$25,186,000.00
Revenue This Year
$69.47
N/A
Revenue Next Year
$8.01
$12.55
P/E Ratio
N/A
$7.38
Revenue Growth
25.68
N/A
52 Week Low
$10.94
$6.00
52 Week High
$17.26
$11.31

Technical Indicators

Market Signals
Indicator
DNOW
BCRX
Relative Strength Index (RSI) 63.37 46.11
Support Level $12.56 $8.73
Resistance Level $16.19 $9.14
Average True Range (ATR) 0.35 0.36
MACD 0.13 -0.12
Stochastic Oscillator 97.30 23.59

Price Performance

Historical Comparison
DNOW
BCRX

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: